Obama Faces Widespread Public Distrust on Iran Deal

Obama Faces Widespread Public Distrust on Iran Deal

By Eric Pianin

President Obama will try to drum up support for the U.S.-Iran nuclear deal Wednesday afternoon at a news conference. But with widespread public disdain and distrust of Iran, Obama may have trouble convincing Americans of the wisdom of dealing with a long-time arch enemy in the Middle East.

The U.S. and Iran on Tuesday announced an agreement that would potentially block Iran’s development of a nuclear weapon for at least a decade while lifting international economic sanctions against Tehran.  However, a new AP-GfK poll that was conducted just ahead of the announcement found that Americans only narrowly back diplomatic relations with the hardline Islamic government, and many want to see the sanctions kept in place.

Related:  The 8 Most Important Things to Know About the Iran Nuclear Deal

Just 51 percent of those interviewed said the U.S. should have diplomatic relations with Iran while 45 percent said it shouldn’t. At the same time, 77 percent of those interviewed said the harsh U.S. and international economic sanctions against Iran should be preserved at current levels or even increased.

Only 12 percent of those interviewed thought sanctions should be decreased and seven percent said they should be eliminated altogether.

The public’s wariness and distrust of dating back to the 1979 Iranian revolution and U.S. hostage crisis matches the reception the nuclear agreement has received on Capitol Hill where most Republicans and some Democrats say they fear Obama has conceded too much to a country that has fomented terrorist activities throughout the Middle East and has repeatedly vowed to destroy Israel.

Fifty-six percent of Americans consider Iran to be an enemy, according to the poll conducted last Thursday through Monday, while an additional 31 percent consider Iran to be unfriendly but not an enemy. More than 70 percent of Republicans, half of all independents and 45 percent of Democrats described Iran as the enemy.

Related: Clinton Cautious in Her Praise of a Nuclear Deal She Helped to Orchestrate

Before the agreement was announced, six in ten Americans said they disapproved of Obama's handling of the U.S. relationship with Iran, while just over a third approved.

Obama is likely to prevail in pushing the nuclear non-proliferation agreement through Congress over the next two months, despite near-unanimous opposition from Senate Majority Leader Mitch McConnell, House Speaker John Boehner and other leaders and rank and file Republicans. Still, he will need to hold in place at least 34 of the 46 Democrats in the Senate to create a veto-proof firewall in the event Republicans push through a resolution of disapproval of the nuclear deal.

That means that Obama cannot afford any more than 12 Democratic defections to keep the agreement alive. Yesterday, Obama and Vice President Joe Biden began working the phones to shore up support on Capitol Hill, and the president will continue that effort during this afternoon’s White House press conference.

During an interview yesterday with Tom Friedman of The New York Times,  Obama stressed that the deal prevented a pathway for Iran to develop a nuclear weapon while making it clear he shared Americans’ distrust of the Iranian government and had limited expectations of improved relations down the road.

Related: Iran Agrees to Limit Nuclear Weapon in Historic Deal

When announcing the deal yesterday, Obama said, “This deal is not built on trust -- it's built on verification…. We will, for the first time, be in a position to verify that Iran is meeting all of these commitments. International nuclear inspectors will have access to Iran's nuclear program -- where necessary, when necessary. This is the most comprehensive and intrusive verification regime that we have ever negotiated. If Iran tries to divert raw materials to covert facilities, inspectors will be able to access any suspicious locations.”

Chart of the Day: Why US Fertility Rates Are Falling

9) Babysit
iStockphoto
By The Fiscal Times Staff

U.S. fertility rates have fallen to record lows for two straight years. “Because the fertility rate subtly shapes many major issues of the day — including immigration, education, housing, the labor supply, the social safety net and support for working families — there’s a lot of concern about why today’s young adults aren’t having as many children,” Claire Cain Miller explains at The New York Times’ Upshot. “So we asked them.”

Here are some results of the Times’ survey, conducted with Morning Consult. Read the full Times story for more details.

A Record Low 47% of US Adults Say They're 'Extremely Proud' to Be American

By The Fiscal Times Staff

Gallup says that, for the first time in the 18 years it’s been asking U.S. adults how proud they are to be Americans, fewer than half say they are "extremely proud." Just 47 percent now say they’re extremely proud, down from 70 percent in 2003.

Another 25 percent say they’re “very proud” — but the combined 72 percent who say they’re extremely or very proud is also the lowest Gallup has recorded. Pride levels among liberals and Democrats have plunged since 2017. Overall, 74 percent of Republicans and just 32 percent of Democrats call themselves “extremely proud” to be American.

Pfizer Has Raised Prices on 100 of Its Products

FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York, U.S. April 28, 2014.  REUTERS/Andrew Kelly/File Photo
Andrew Kelly
By The Fiscal Times Staff

Weeks after President Trump said that drugmakers were about to implement “voluntary massive drops in prices” — reductions that have yet to materialize — Pfizer has raised prices on 100 of its products, The Financial Times’s David Crow reports:

“The increases were effective as of July 1 and in most cases were more than 9 per cent — well above the rate of inflation in the US, which is running at about 2 per cent. … Pfizer, the largest standalone drugmaker in the US, did decrease the prices of five products by between 16 per cent and 44 per cent, according to the figures.”

Crow notes that Pfizer also raised prices on many of its medicines in January, meaning that some prices have been hiked by nearly 20 percent this year. The drugmaker said that it was only changing prices on 10 percent of its medicines and that list prices did not reflect what most patients or insurers actually paid. The net price increase after rebates and discounts was expected to be in the “low single digits,” the company told the FT.

Chart of the Day: Pass-Through Tax Deductions Made Easy

iStockphoto
By Michael Rainey

The Republican tax overhaul was supposed to simplify the tax code, but most experts say it fell well short of the goal. Martin Sullivan, chief economist at Tax Analysts, tweeted out a chart of the analysis required to determine whether income qualifies for the passthrough tax deduction of 20 percent, and as you’ll see, it’s anything but simple. 

A Conservative Bashes GOP Dysfunction on Spending Cuts

iStockphoto/The Fiscal Times
By The Fiscal Times Staff

Brian Riedl, a senior fellow at the conservative Manhattan Institute, offers a blistering critique of congressional Republican’s problems cutting spending:

Since the Republicans took the House in 2011, nearly every annual budget blueprint has promised to balance the budget within a decade with anywhere from $5 trillion to $8 trillion in spending cuts. And yet, you may have noticed, the budget has not moved towards balance. This is because the budget merely sets a broad fiscal goal. To actually cut spending, Congress must follow up with specific legislation to reform Medicare, Medicaid, and all the other targeted programs. In reality, most lawmakers who pass these budgets have no intention whatsoever of cutting this spending. As soon as the budget is passed, the targets are forgotten. The spending-cut legislation is never even drafted, much less voted on.

The annual budget exercise is thus a cynical exercise in symbolism. Congress calculates how much spending must be cut over ten years to balance the budget. Then they pass legislation setting a goal of cutting that amount. Then they move on to other business. It’s like a baseball team announcing that they voted to win the next World Series, and then not showing up to play the season.

Read the full piece at National Review.